Management of alloimmunization depends on the clinical scenario. For transfusion-dependent patients, selecting compatible blood through extensive antigen matching is crucial. In pregnancy, close monitoring of antibody levels and fetal health is essential. In severe cases of HDFN, intrauterine transfusions or early delivery might be necessary.
